Clinical Trials Logo

Crohn Disease of Vulva clinical trials

View clinical trials related to Crohn Disease of Vulva.

Filter by:
  • None
  • Page 1

NCT ID: NCT04519697 Recruiting - Crohn Disease Clinical Trials

Mesenchymal Stem Cells for the Treatment of Rectovaginal Fistulas in Participants With Crohn's Disease

RVF
Start date: October 28, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Approximately 10% of all female Crohn's patients have a rectovaginal fistula. Rectovaginal fistulas cause air, stool, and/or drainage per vagina and may be associated with pain, recurrent urinary tract infections and diminished quality of life. Conventional therapy includes immunosuppressive medications used to treat Crohn's disease and various surgical interventions. However, all have limited ability to heal these fistulas. The purpose of this study is to determine the safety and efficacy of using allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat people with rectovaginal fistulas in the setting of Crohn's disease.